Cancer Articles
How an Old Diabetes Drug – Pioglitazone Shows Promise in Fighting Leukemia
Acute myeloid leukemia (AML) is an aggressive cancer of the blood and bone marrow that affects thousands of people worldwide. Traditional treatments often come with severe side effects, especially for…
Can Metformin and a Cholesterol Medicine be Useful Against Brain Cancer?
Gliomas are the most common type of malignant brain tumors in adults, with glioblastoma (GBM) being the most aggressive and deadliest form. Despite significant advancements in medical research, the prognosis…
Metformin: A Promising Add-On Therapy for DFSP Skin Cancer
In the realm of cancer research, innovative treatment options continue to transform therapeutic approaches. A recent study in Cell Organoid highlights metformin’s role, commonly used for diabetes, as a promising…
GLP-1 Receptor Agonists: A Promising Avenue for Reducing Liver Cancer Risk in Type 2 Diabetes Patients
Hepatocellular carcinoma (HCC) stands as one of the most lethal cancers worldwide, with rising incidence rates paralleling the global increase in obesity, type 2 diabetes, and nonalcoholic fatty liver disease…
SGLT2 Inhibitors: A Promising New Approach in Cancer Treatment
Discover how SGLT2 inhibitors, beyond managing diabetes, are emerging as promising anticancer agents by targeting cancer cell metabolism and inhibiting tumor growth.Cancer remains one of the leading causes of death…
Metformin: A Promising Ally in the Fight Against Colorectal Cancer
Summary: Metformin, primarily a diabetes medication, shows potential in treating colorectal cancer (CRC) due to its ability to regulate gene expression and metabolic pathways. Recent studies highlight its anti-cancer effects…
Metformin in Prediabetes: Role in Prevention and Impact on Vitamin B12 Absorption
Understanding PrediabetesPrediabetes is a metabolic condition where blood sugar levels are higher than normal but not high enough to be classified as type 2 diabetes. It is diagnosed using criteria…
Colorectal Cancer (CRC) and Metformin: A Promising Combination for Prevention and Treatment in Diabetic Individuals
Colorectal cancer (CRC) is the third most common malignancy worldwide for both men and women. According to the World Health Organization (WHO), approximately 1.9 million new cases were diagnosed in…
Osteosarcoma: Metformin’s Potential Future Role in Treatment
Osteosarcoma is the most common type of primary bone cancer, affecting adolescents and young adults at an incidence rate of 3-4 cases per million people annually. This aggressive malignancy usually…
Can Metformin Revolutionize the Treatment of Acute Lymphoblastic Leukemia (ALL)?
Acute lymphoblastic leukemia (ALL) is a cancer affecting lymphocytes, primarily impacting children but also prevalent in adults over 50. With an incidence rate of 1-4 per 100,000 globally, ALL is…
Metformin and Endometrial Cancer: A Comprehensive, Evidence-Based Overview (2024)
Endometrial cancer is one of the most common gynecological cancers, particularly affecting postmenopausal women. With obesity rates rising and contributing to increased estrogen levels, the incidence of endometrial cancer continues…
How Metformin Ameliorates the Metabolic Side Effects of Antiretroviral Therapy (ART) in HIV Patients
Metformin has gained attention for its potential to alleviate metabolic side effects associated with Antiretroviral Therapy (ART) in HIV patients. These side effects, including insulin resistance and fat redistribution (lipodystrophy),…